Taipei Exchange - Delayed Quote TWD

SSLab (7790.TWO)

81.80
0.00
(0.00%)
At close: 2:57:05 PM GMT+8
Loading Chart for 7790.TWO
  • Previous Close 81.80
  • Open 81.80
  • Bid 78.50 x --
  • Ask 81.80 x --
  • Day's Range 81.80 - 81.80
  • 52 Week Range 67.50 - 92.00
  • Volume 9
  • Avg. Volume 21,015
  • Market Cap (intraday) 1.301B
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) 247.88
  • EPS (TTM) 0.33
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Spirit Scientific Co., Ltd., a med-tech company, focuses on minimal invasive treatment for orthopedic pain relief. It offers Vessel-X, a bone filling containment system to treat patients with spinal compression fractures; various orthopedic medical devices; and platelet-lyophilized-treatment technology for the treatment of osteoarthritis and sports injuries. The company was founded in 2013 and is based in Taipei, Taiwan.

www.spirit-scientific.com

--

Full Time Employees

December 31

Fiscal Year Ends

Recent News: 7790.TWO

View More

Performance Overview: 7790.TWO

Trailing total returns as of 5/15/2025, which may include dividends or other distributions. Benchmark is TSEC CAPITALIZATION WEIGHTED ST (^TWII) .

YTD Return

7790.TWO
16.03%
TSEC CAPITALIZATION WEIGHTED ST (^TWII)
5.66%

1-Year Return

7790.TWO
2.04%
TSEC CAPITALIZATION WEIGHTED ST (^TWII)
2.76%

3-Year Return

7790.TWO
2.04%
TSEC CAPITALIZATION WEIGHTED ST (^TWII)
37.25%

5-Year Return

7790.TWO
2.04%
TSEC CAPITALIZATION WEIGHTED ST (^TWII)
100.93%

Compare To: 7790.TWO

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 7790.TWO

View More

Valuation Measures

Annual
As of 5/14/2025
  • Market Cap

    1.30B

  • Enterprise Value

    1.07B

  • Trailing P/E

    247.88

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    5.54

  • Price/Book (mrq)

    3.62

  • Enterprise Value/Revenue

    4.72

  • Enterprise Value/EBITDA

    32.91

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    2.23%

  • Return on Assets (ttm)

    1.21%

  • Return on Equity (ttm)

    1.50%

  • Revenue (ttm)

    226.39M

  • Net Income Avi to Common (ttm)

    5.05M

  • Diluted EPS (ttm)

    0.33

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    262.28M

  • Total Debt/Equity (mrq)

    8.44%

  • Levered Free Cash Flow (ttm)

    -42.15M

Research Analysis: 7790.TWO

View More

Company Insights: 7790.TWO

Research Reports: 7790.TWO

View More